Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
Hepatocellular carcinoma (HCC) represents a leading cause of cancer-related death, but it remains difficult to treat. Intratumor genetic and phenotypic heterogeneity are inherent properties of breast, skin, lung, prostate, and brain tumors, and intratumor heterogeneity (ITH) helps define prognosis a...
Saved in:
Main Authors: | Sharanya Maanasi Kalasekar, Chad H. VanSant-Webb, Kimberley J. Evason |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/40e749afbae64edf93d626e3af8de048 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Portrait of Intratumoral Genomic and Transcriptomic Heterogeneity at Single-Cell Level in Colorectal Cancer
by: Andrea Angius, et al.
Published: (2021) -
Tumor Heterogeneity and Consequences for Bladder Cancer Treatment
by: Etienne Lavallee, et al.
Published: (2021) -
Intratumoral Heterogeneity and Immune Response Indicators to Predict Overall Survival in a Retrospective Study of HER2-Borderline (IHC 2+) Breast Cancer Patients
by: Gedmante Radziuviene, et al.
Published: (2021) -
Multiscale heterogeneity in gastric adenocarcinoma evolution is an obstacle to precision medicine
by: Christoph Röcken, et al.
Published: (2021) -
Advances in Injectable In Situ-Forming Hydrogels for Intratumoral Treatment
by: Gi Ru Shin, et al.
Published: (2021)